ARCHIVES

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

This article is from The Cancer Letter archive.

Vol. 09 No. 25 | June 24, 1983

Download PDF Visit The Full Archive

Related Articles

Cuts From NCI Budget total $38 Million; Prevention Gets $21 Million Increase

January 24, 1992

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

Stand Up To Cancer Says $80 Million in Pledges Raised

September 17, 2010

Letter: Biostatistics Directors Invited To Share Concerns

June 7, 1996

Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote

April 2, 1976

Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change.

September 30, 2005